Master of Science in Interdisciplinary Oncology (MSc)
The Interdisciplinary Oncology program (IOP) is a graduate program designed to appeal to a broad range of students interested in cancer research. IOP offers advanced study and research in a variety of fields relating to oncology. Those fields include: molecular and cellular biology, genetics, biophysics, bioinformatics, pharmaceutical sciences, radiological sciences, immunology, molecular pathology, sociobehavioral studies, epidemiology and health economics. The goal of the program is to provide graduate students from diverse backgrounds, with an education in a number of disciplines relating to oncology, and to provide training opportunities for intensive training in specialized aspects of cancer research. For more than ten years, the program has been training the next generation of cancer research leaders.
What makes the program unique?
IOP integrates the diverse areas of oncology by offering two required courses which provide an interdisciplinary perspective on oncology in a form that is accessible to students from diverse backgrounds. The elective courses provide intensive training in one or more subjects specific to the student's research, and also gives the student an opportunity to gain expertise in other disciplines that have potential for synergy with their primary specialization. Students have access to clinicians and university faculty through the world-renowned BC Cancer Agency, to get a practical perspective on oncology treatments and outcomes. An innovative rotation course is a unique option for students to gain hands-on experience by rotating through specialty laboratories and by shadowing clinicians.
Most IOP supervisors reside off-campus at the BC Cancer Research Centre, the Prostate Centre at Vancouver General Hospital or other hospital-related buildings.
Students must secure a supervisor before they can be admitted into the program. As well, they must meet the minimum admission requirements set out by Graduate and Post-doctoral Studies at UBC.
CV, Official transcripts, three letters of reference, Official English exam scores (if required)
TOEFL (ibT) Overall Score Requirement
IELTS Overall Score Requirement
Supervisor commitment required prior to application?
Prior degree requirements
A B.Sc is the minimum requirement.
All students who secure a supervisor and who are enrolled in the program will be paid a minimum stipend of $22,000/year.
Tuition / Program Costs
|Fees||Canadian Citizen / Permanent Resident / Refugee / Diplomat||International|
|Installments per year||3||3|
|Tuition per installment||$1,632.61||$2,868.22|
|Tuition per year||$4,897.83||$8,604.66|
|Int. Tuition Award (ITA) per year (if eligible)||$3,200.00 (-)|
|Other Fees and Costs|
|Student Fees (yearly)||$923.38 (approx.)|
|Costs of living (yearly)||starting at $16,884.10 (check cost calculator)|
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
Completion Rates & Times
This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.
Aparicio, Samuel (Breast cancer, genome sequencing )
Bally, Marcel Bertran (Pancreas centre)
Baumbusch, Jennifer (long-term residential care, family caregiving, Intellectual Disability, nursing care of older adults )
Benard, Francois (Medical isotopes Radioisotopes Nuclear Medicine Cancer Imaging Molecular imaging of cancer Radionuclide therapy, Cancer division, radiology, pancreas centre)
Bennewith, Kevin (Oncology; Molecular Pathology & Cell Biology; Cancer research; Solid tumour microenvironment; Hypoxia; Metastasis research; Pre-metastatic niche; Targeting hypoxic tumour cells in therapy; Radiation biology)
Brooks-Wilson, Angela (human genetics, cancer genetics, cancer families, longevity, Super seniors, genetic susceptibility)
Brown, Carolyn Janet (Epigenetic control of gene expression, X-chromosome inactivation, Long non-coding RNAs, XIST RNA, Genes escaping X-chromosome inactivation, DNA methylation)
Burgess, Michael (Philosophy and social sciences, ethics and social policy in the areas of genomics, genetics and biotechnology (health, agriculture and environment))
Buttyan, Ralph (Kidneys, Urinary System, Benign Bladder Dysfunctions)
Campbell, Kristin (Exercise, cancer prevention, cancer rehabilitation, cancer survivorship, physical activity, biomarkers, energy balance, obesity )
Cox, Michael (genetic testing, experiences of hereditary risk, social and ethical implications of genetics, interpersonal and family communication, qualitative research, narrative and story, Prostate cancer)
Daugaard, Mads (Cancer biology, Glycobiology, DNA damage response pathways, Cancer therapy, Cancer diagnostics, Stress signalling in cancer, Immunotherapy)
Dedhar, Shoukat (molecular biology, molecular biology as it relates to disease; developing new theraputics for cancer; how brain cells (neurons)make connections, therapeutics for cancer; molecular genetics and cancer; medical research, cancer, inflammatory diseases, cariovascular diseases, Cellular proteins, extracellular martrix, integrins, signal transduction, calreticulin, protein kinase, gene expression, cell differentiation)
Dong, Xuesen (understand how steroid receptors regulate gene expression and apply this knowledge to treating patients with prostate cancer and premature labour)
Duronio, Vincent (Signal transduction, enzymes, cell regulation, programmed cell death, apoptosis, protein kinase, phosphorylation networks, oxidized LDL, macrophages, gene regulation)
Eaves, Constance Jean (Normal and leukemic stem cells, normal and malignant breast stem cells)
Garnis, Catherine (Cancer biology; Tumor progression; Oral premalignant lesions; Head and neck cancer; RNA biology, microRNAs; Alternative splicing; Biomarkers)
Gleave, Martin (Infectious diseases, interdisciplinary oncology, prostate)
Guns, Emma (pharmacology, ADMET, drug discovery, mass spectrometry, natural products, cancer cell biology, steroidogenesis in oncology, hormone receptor targeting and pathway analysis (pharmacodynamics), extracellular vesicles in cancer cell communication)
Hieter, Philip (Molecular biology of eukaryotic chromosome transmission )
Holt, Robert (Immunogenetics, Metagenomics - Infectious agents in Cancer, Cancer Genomes, Neurobiology, DNA Sequencing)
Howard, Fuchsia (health service needs of vulnerable, high-risk survivors of acute life-threatening illness, specifically, cancer survivors and survivors of critical illnesses; hereditary cancer prevention and risk management and psychosocial and ethnocultural factors that shape health and illness experiences)
Humphries, Richard Keith (Genetic control and manipulation of hemopoiesis. Stem Cell Regulation. Retroviral Gene Transfer. Transgenic Mice.)
Huntsman, David (hereditary cancer, molecular pathology, cancer biomarkers, Pancreas centre)
Jia, William Wei-Guo (Brain tumour, Oncolytic virotherapy, Virus mediated genetherapy, Degenerative neurological diseases, Drug discovery from natural products, neurosurgery)